These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34628169)

  • 1. REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model.
    Wang S; Kozai M; Mita H; Cai Z; Masum MA; Ichii O; Takada K; Inaba M
    Biomed Pharmacother; 2021 Dec; 144():112283. PubMed ID: 34628169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock.
    Ishimaru K; Nakajima S; Yu G; Nakamura Y; Nakao A
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice.
    Morioka N; Kodama K; Tomori M; Yoshikawa K; Saeki M; Nakamura Y; Zhang FF; Hisaoka-Nakashima K; Nakata Y
    Brain Behav Immun; 2019 May; 78():116-130. PubMed ID: 30682503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression.
    Amador A; Wang Y; Banerjee S; Kameneka TM; Solt LA; Burris TP
    PLoS One; 2016; 11(3):e0151014. PubMed ID: 26963516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation.
    Amador A; Huitron-Resendiz S; Roberts AJ; Kamenecka TM; Solt LA; Burris TP
    PLoS One; 2016; 11(9):e0162452. PubMed ID: 27603791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
    Okura I; Kamata M; Asano Y; Mitsui A; Shimizu T; Sato S; Tada Y
    J Dermatol Sci; 2021 May; 102(2):116-125. PubMed ID: 33888401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REV-ERB Agonist SR9009 Regulates the Proliferation and Neurite Outgrowth/Suppression of Cultured Rat Adult Hippocampal Neural Stem/Progenitor Cells in a Concentration-Dependent Manner.
    Shimozaki K
    Cell Mol Neurobiol; 2022 Aug; 42(6):1765-1776. PubMed ID: 33599915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome.
    Hong H; Cheung YM; Cao X; Wu Y; Li C; Tian XY
    Biochem Pharmacol; 2021 Oct; 192():114701. PubMed ID: 34324866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.
    Shen W; Zhang W; Ye W; Wang H; Zhang Q; Shen J; Hong Q; Li X; Wen G; Wei T; Zhang J
    Theranostics; 2020; 10(10):4466-4480. PubMed ID: 32292508
    [No Abstract]   [Full Text] [Related]  

  • 12. REV-ERBs negatively regulate mineralization of the cementoblasts.
    Fu L; Wang M; Zhu G; Zhao Z; Sun H; Cao Z; Xia H
    Biochem Biophys Res Commun; 2022 Jan; 587():9-15. PubMed ID: 34861472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism.
    Stujanna EN; Murakoshi N; Tajiri K; Xu D; Kimura T; Qin R; Feng D; Yonebayashi S; Ogura Y; Yamagami F; Sato A; Nogami A; Aonuma K
    PLoS One; 2017; 12(12):e0189330. PubMed ID: 29232411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence.
    Sulli G; Rommel A; Wang X; Kolar MJ; Puca F; Saghatelian A; Plikus MV; Verma IM; Panda S
    Nature; 2018 Jan; 553(7688):351-355. PubMed ID: 29320480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SR9009 has REV-ERB-independent effects on cell proliferation and metabolism.
    Dierickx P; Emmett MJ; Jiang C; Uehara K; Liu M; Adlanmerini M; Lazar MA
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12147-12152. PubMed ID: 31127047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological modulation and genetic deletion of REV-ERBα and REV-ERBβ regulates dendritic cell development.
    Amir M; Campbell S; Kamenecka TM; Solt LA
    Biochem Biophys Res Commun; 2020 Jul; 527(4):1000-1007. PubMed ID: 32439175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of nuclear receptor REV-ERBs suppresses inflammatory responses in spinal microglia.
    Morioka N; Kodama K; Tsuruta M; Hashizume H; Kochi T; Nakamura Y; Zhang FF; Hisaoka-Nakashima K
    Neurochem Int; 2021 Dec; 151():105216. PubMed ID: 34710533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
    Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.